Rhythm Pharmaceuticals, Inc. (RYTM) Documents: SEC Filings, Investor Presentations & Press Releases

Rhythm Pharmaceuticals, Inc. (RYTM) documents, SEC filings and the IR site together: 100 documents, newest first; latest 2026-08-04. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-048-KForm 8-K, Item 2.02 results
2026-08-0410-QForm 10-Q for the quarter ended Jun 30
2026-06-258-KForm 8-K, Item 5.07
2026-06-158-KForm 8-K, Item 7.01
2026-05-058-KForm 8-K, Item 2.02 results
2026-05-0510-QForm 10-Q for the quarter ended Mar 31
2026-04-29ProxyDefinitive proxy statement
2026-04-038-KForm 8-K, Item 5.02
2026-03-268-KForm 8-K, Item 7.01
2026-03-208-KForm 8-K, Item 7.01
2026-03-168-KForm 8-K, Item 7.01
2026-03-028-KForm 8-K, Item 7.01
2026-02-27TranscriptQ4 FY25 earnings call transcript
2026-02-268-KForm 8-K, Item 2.02 results
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-01-098-KForm 8-K, Item 2.02 results
2025-12-198-KForm 8-K, Item 5.02
2025-12-118-KForm 8-K, Item 7.01
2025-11-078-KForm 8-K, Item 7.01
2025-11-048-KForm 8-K, Item 2.02 results
2025-11-0410-QForm 10-Q for the quarter ended Sep 30
2025-10-31DeckInvestor presentation · Oct 2025
2025-10-29DeckPoster
2025-10-24DeckPoster
2025-10-15DeckPoster
2025-08-06TranscriptQ2 FY25 earnings call transcript
2025-08-058-KForm 8-K, Item 2.02 results
2025-08-0510-QForm 10-Q for the quarter ended Jun 30
2025-07-118-KForm 8-K, Item 8.01
2025-07-098-KForm 8-K, Item 7.01
2025-06-268-KForm 8-K, Item 5.03
2025-05-078-KForm 8-K, Item 2.02 results
2025-05-0710-QForm 10-Q for the quarter ended Mar 31
2025-04-29ProxyDefinitive proxy statement
2025-04-078-KForm 8-K, Item 7.01
2025-03-208-KForm 8-K, Item 1.02
2025-02-288-KForm 8-K, Item 8.01
2025-02-2810-KAnnual report on Form 10-K, FY24
2025-02-268-KForm 8-K, Item 2.02 results
2025-01-108-KForm 8-K, Item 2.02 results

RYTM overview · RYTM earnings · RYTM financials · RYTM KPIs · RYTM ownership · RYTM peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.